Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

29
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
29
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

934
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
934
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

187
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
187
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

211
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
211
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

256
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
256

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-Modality Image Registration via Generating Aligned Image Using Reference-Augmented Framework.

IEEE journal of biomedical and health informatics·2025
Same author

Quantifying U.S. life expectancy gains from reductions in Black-White mortality disparities: A simulation study.

Annals of epidemiology·2025
Same author

Impacts of SNAP benefit increases on US child food insufficiency during the COVID-19 pandemic.

Journal of epidemiology and community health·2025
Same author

Temporal Bone CT Findings in Hajdu-Cheney Syndrome: Case Report with Review of the Literature.

AJNR. American journal of neuroradiology·2025
Same author

Breast cancer patients treated at a New York City academic health system during the COVID-19 pandemic in 2021 had delayed presentations and more advanced disease than pre-pandemic cases.

Breast cancer research and treatment·2025
Same author

Large Language Models for Accessible Reporting of Bioinformatics Analyses in Interdisciplinary Contexts.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Sep 20, 2025

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
08:05

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

Published on: December 9, 2022

4.4K

Complication Rates in Patients Using Intracavernosal Injection Therapy for Erectile Dysfunction With or Without

Kyle A Blum1, Justin P Mehr2, Travis Green1

  • 1Department of Surgery, Division of Urology, University of Texas McGovern Medical School, Houston, TX, USA; Department of Urology, MD Anderson Cancer Center, Houston, TX, USA.

Sexual Medicine
|June 6, 2022
PubMed
Summary
This summary is machine-generated.

Intracavernosal injection therapy (ICI) for erectile dysfunction (ED) may be safe for patients on anticoagulants (AC), despite a higher absolute bleeding complication rate. Further research is needed to confirm safety and bleeding risk.

Keywords:
AnticoagulationBleedingErectile DysfunctionErectile Dysfunction Inventory for Treatment Satisfaction (EDITS) QuestionnaireIntracavernosal Injection

More Related Videos

Combination of High Ligation and Intraoperative Embolization using Polidocanol for Treatment of Varicoceles
02:58

Combination of High Ligation and Intraoperative Embolization using Polidocanol for Treatment of Varicoceles

Published on: December 22, 2023

493
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.8K

Related Experiment Videos

Last Updated: Sep 20, 2025

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
08:05

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

Published on: December 9, 2022

4.4K
Combination of High Ligation and Intraoperative Embolization using Polidocanol for Treatment of Varicoceles
02:58

Combination of High Ligation and Intraoperative Embolization using Polidocanol for Treatment of Varicoceles

Published on: December 22, 2023

493
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.8K

Area of Science:

  • Urology
  • Andrology
  • Pharmacology

Background:

  • Intracavernosal injection therapy (ICI) is a primary treatment for erectile dysfunction (ED).
  • Concurrent use of anticoagulants (AC) with ICI raises theoretical bleeding concerns.
  • Limited data exists on complication rates for patients on AC using ICI.

Purpose of the Study:

  • To compare bleeding and complication rates in patients using ICI with or without concurrent AC use.
  • To evaluate the safety of ICI therapy in patients undergoing anticoagulant treatment.

Main Methods:

  • Retrospective review of electronic health records for 168 patients using ICI for ED (January-August 2020).
  • Survey data and Erectile Dysfunction Inventory for Treatment Satisfaction scores collected from 85 patients.
  • Comparison between 43 patients on AC and 42 patients not on AC using Fisher's exact test and t-tests.

Main Results:

  • A higher absolute incidence of bleeding complications was observed in the AC group (7%) compared to the non-AC group (0%).
  • No statistically significant difference in overall or stratified bleeding events and complications was found between the groups.
  • Mean Erectile Dysfunction Inventory for Treatment Satisfaction scores were compared between groups.

Conclusions:

  • While absolute bleeding events were higher in the anticoagulant group, ICI therapy may be a safe treatment for ED in patients on AC.
  • The study's single-center, retrospective design and small sample size limit definitive conclusions.
  • Larger, prospective studies are warranted to accurately assess bleeding risks associated with ICI in patients on anticoagulants.